Armis Biopharma, Inc. — Form D

Armis Biopharma, Inc. of FORT COLLINS, CO, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-25. The offering totals $10.0M, of which $1.8M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (33)

Showing 25 of 33 people.

NameRoleLocation
Stephen CoderDirectorFort Collins, CT
Ed NeasDirectorFort Collins, CO
William NelsonDirectorLas Vegas, NV
Alan SmithDirectorRydal, PA
Dennis TemplarDirectorFort Collins, CO
Robert KaliExecutive OfficerFort Collins, CO
Dennis TemplarExecutive OfficerFort Collins, CO
Michael HandleyDirectorFremont, CA
Michael HandleyExecutive OfficerFremont, CA
Theodore ZiemannDirectorFort Collins, CO
Alan RuudDirectorFort Collins, CO
Steve CoderDirectorFort Collins, CO
Steve CoderExecutive OfficerFort Collins, CO
Michael VossDirectorAustin, TX
Michael VossExecutive OfficerAustin, TX
William Nelson, MD, Ph.D.DirectorFort Collins, CO
Michael LitwackDirectorFort Collins, CO
Alan Smith, Ph.D.DirectorFort Collins, CO
Christopher RuddDirectorFort Collins, CO
Ted ZiemannDirectorFort Collins, CO
Ted ZiemannExecutive OfficerFort Collins, CO
William Nelson, MD. Ph.D.DirectorFort Collins, CO
Ed Neas, Ph.D.DirectorFort Collins, CO
Christopher RuudDirectorFort Collins, CO
Christopher RuudExecutive OfficerFort Collins, CO

Other filings by this issuer (13)

FiledFormOfferingSold
2025-07-10D$3.0M$1.0M
2022-09-15D/A$10.0M$7.3M
2022-02-15D$8.0M$5.3M
2017-11-17D$30.0M$125K
2017-11-17D/A$14.0M$2.7M
2017-05-12D/A$14.0M$2.7M
2017-02-09D/A$14.0M
2017-01-27D$14.0M
2016-06-01D/A$5.8M$3.3M
2016-03-10D$5.8M$758K
2016-02-26D$1.7M$1.7M
2014-04-17D/A$3.2M$3.2M
2014-04-14D$2.5M$2.5M

More